Altimmune Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	97.64	43.8	36.97	135.16	111.13	190.34
Short-Term Investments	233.94	229.7	94.97	62.7	73.78	-
Cash & Short-Term Investments	331.58	273.5	131.93	197.86	184.91	190.34
Cash Growth	121.25%	107.30%	-33.32%	7.00%	-2.85%	-11.87%
Accounts Receivable	1.67	1.22	0.54	1.11	0.17	0.43
Other Receivables	-	0.52	2.57	3.74	2.37	5.41
Total Trade Receivables	1.67	1.74	3.12	4.85	2.54	5.84
Other Current Assets	1.43	2.96	2.2	6.92	5.36	7.95
Total Current Assets	334.68	278.19	137.25	209.63	192.81	204.13
Net Property, Plant & Equipment	0.21	0.31	0.41	0.65	1.08	1.45
Other Intangible Assets	-	-	-	-	12.42	12.42
Other Long-Term Assets	0.75	1.43	1.64	0.36	0.62	0.87
Total Assets	335.63	279.93	139.31	210.64	206.93	218.87
Accounts Payable	1.53	2.72	0.21	2.07	4.8	2.03
Accrued Expenses	9.79	12.28	10.26	10.07	12.25	10.15
Other Current Liabilities	-	-	-	-	-	6.09
Total Current Liabilities	11.32	15	10.47	12.14	17.05	18.28
Long-Term Debt	34.51	34.29	-	-	-	-
Other Long-Term Liabilities	5.82	5.75	5.33	4.4	4.58	1.45
Total Long-Term Liabilities	40.32	40.04	5.33	4.4	4.58	1.45
Total Liabilities	51.64	55.04	15.8	16.54	21.64	19.73
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	961.24	879.29	689.86	665.43	568.4	497.34
Accumulated Other Comprehensive Income	-5.22	-4.93	-4.97	-5	-5.23	-5.04
Retained Earnings	-672.05	-649.48	-561.39	-466.33	-377.88	-293.17
Shareholders' Equity	283.99	224.89	123.51	194.1	185.29	199.14
Total Liabilities & Equity	335.63	279.93	139.31	210.64	206.93	218.87
Total Debt	34.51	34.29	0	0	0	0
Net Cash (Debt)	297.08	239.21	131.93	197.86	184.91	190.34
Net Cash Growth	24.19%	81.31%	-33.32%	7.00%	-2.85%	-11.87%
Net Cash Per Share	3.00	2.71	1.86	3.72	3.94	4.61
Book Value	283.99	224.89	123.51	194.1	185.29	199.14
Book Value Per Share	2.87	2.55	1.74	3.65	3.95	4.82
Tangible Book Value	283.99	224.89	123.51	194.1	172.87	186.72
Tangible Book Value Per Share	2.87	2.55	1.74	3.65	3.68	4.52

SEC Filings: 10-K · 10-Q